Real-World Persistence of Upadacitinib for Atopic Dermatitis: Expanded Analysis From Royal Melbourne Hospital Biogrid Registry and the Australasian Dermatology Registry.

Abu-Ghazaleh N, Armstrong J, Morgan V, Ross G.

Open source

DOI
10.1111/ajd.70188
Published
2026-08-05
Container
Australas J Dermatol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ajd.70188,
  title = {Real-World Persistence of Upadacitinib for Atopic Dermatitis: Expanded Analysis From Royal Melbourne Hospital Biogrid Registry and the Australasian Dermatology Registry.},
  author = {Abu-Ghazaleh N and  Armstrong J and  Morgan V and  Ross G.},
  year = {2026},
  journal = {Australas J Dermatol},
  doi = {10.1111/ajd.70188},
  url = {https://doi.org/10.1111/ajd.70188}
}

RIS

TY  - JOUR
TI  - Real-World Persistence of Upadacitinib for Atopic Dermatitis: Expanded Analysis From Royal Melbourne Hospital Biogrid Registry and the Australasian Dermatology Registry.
AU  - Abu-Ghazaleh N
AU  -  Armstrong J
AU  -  Morgan V
AU  -  Ross G.
PY  - 2026
JO  - Australas J Dermatol
DO  - 10.1111/ajd.70188
UR  - https://doi.org/10.1111/ajd.70188
ER  - 

APA

N, A., J, A., V, M., & G., R. (2026). Real-World Persistence of Upadacitinib for Atopic Dermatitis: Expanded Analysis From Royal Melbourne Hospital Biogrid Registry and the Australasian Dermatology Registry.. Australas J Dermatol. https://doi.org/10.1111/ajd.70188

Source records